Visit
April 15th saw the Food and Drug Administration (FDA) approval of mitomycin gel (Jelmyto) for the treatment of low-grade upper…
The early detection of cancer improves outcomes for patients – in terms of both reducing treatment burden and improving the…
Metastatic castration-resistant prostate cancer (mCRPC) has limited treatment options and metastatic growth is associated with increased comorbidities. To put the…
Following the release of trial data, the FDA has approved erdafitinib for the treatment of adult patients with fibroblast growth…
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest oncology news and updates
Keep up to date with all the latest news with our monthly newsletter